How is linaclotide used in the treatment of constipation and what was the FDA approval based on?

Updated: Mar 30, 2020
  • Author: Marc D Basson, MD, PhD, MBA, FACS; Chief Editor: BS Anand, MD  more...
  • Print

Linaclotide was approved by the US Food and Drug Administration (FDA) in August 2012 to treat chronic idiopathic constipation and for IBS with constipation (IBS-C) in adults. Approval was based on randomized controlled trials that showed significant improvement for each indication compared with placebo. [32, 33, 34]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!